MDGL
Madrigal Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.6% ·
aandelenstroom -2.9% ·
netto nieuwe posities 0.0%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 123 | +1 | 10.48M | $5.62B | +9 | −7 |
| Q1 2026 | 124 | +7 | 12.07M | $6.32B | +9 | −3 |
| Q4 2025 | 116 | 0 | 12.47M | $7.26B | +1 | — |
| Q3 2025 | 19 | +1 | 6.80M | $3.12B | +1 | −1 |
| Q2 2025 | 16 | 0 | 6.45M | $1.95B | — | — |
| Q1 2025 | 13 | +1 | 2.28M | $753.61M | +1 | — |
| Q4 2024 | 12 | +2 | 2.15M | $662.73M | +2 | — |
| Q3 2024 | 9 | +1 | 1.41M | $299.66M | +3 | −2 |
| Q2 2024 | 8 | — | 1.43M | $401.79M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 1.81M | -3.5% | $831.12M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passief) | 1.56M | +8.4% | $715.38M | 0.0% | ▲ Add | 2 | SEC ↗ ×15 |
| 3 | State Street Global Advisors ✦ (passief) | 658.10K | -4.7% | $301.84M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 446.23K | +7.7% | $204.70M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 404.45K | +5381.2% | $185.51M | 0.0% | ▲ Add | 5 | SEC ↗ ×7 |
| 6 | Fidelity (FMR) ✦ | 401.14K | -9.9% | $183.99M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 7 | Goldman Sachs Group ✦ | 386.10K | — | $177.09M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 8 | T. Rowe Price ✦ | 352.52K | -30.7% | $161.69M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 249.65K | — | $114.50M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 10 | Renaissance Technologies ✦ | 120.68K | +1013.7% | $55.35M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 96.18K | -14.1% | $44.11M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 12 | JPMorgan Chase ✦ | 95.65K | — | $43.87M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 13 | Adage Capital Partners ✦ | 88.50K | -76.5% | $40.59M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 48.37K | -76.7% | $22.19M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | Point72 Asset Management ✦ | 41.23K | -62.8% | $18.91M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 27.79K | Nieuw | $12.74M | 0.1% | New | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 6.59K | +108.0% | $3.02M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 18 | Millennium Management ✦ | 1.80K | -83.4% | $824,671 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Marshall Wace ✦ | 700 | -98.7% | $321,062 | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Bridgewater Associates | $12.74M | 0.1% |
Verlaten
| Norges Bank | $53.41M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 374 houders, 23.71M aandelen, $12.08B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 120 aand · $65,565
Officer, Director · 60 aand · $31,985
Officer, Director · 106 aand · $56,611
Officer, Director · 218 aand · $116,836
Officer, Director · 160 aand · $86,019
Officer, Director · 687 aand · $371,382
Officer, Director · 368 aand · $199,324
Officer, Director · 1.20K aand · $652,209
Officer, Director · 1.54K aand · $837,253
Officer, Director · 761 aand · $414,616
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie